uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Other Non Operating Income (2016 - 2026)

uniQure (QURE) posted quarterly Other Non Operating Income of -$16.0 million for Q2 2026, down 185.69% year-over-year from $18.6 million in Q2 2025, and down 523.72% quarter-over-quarter from $3.8 million in Q1 2026.

Analysis

uniQure (QURE) Other Non Operating Income (2016 - 2026) Analysis & Trends

uniQure's Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$16.0 million for Q2 2026.

  • In Q2 2026, Other Non Operating Income fell 185.69% year-over-year to -$16.0 million; the TTM figure through Jun 2026 stood at -$18.7 million (down 207.09% YoY), while the FY2025 annual figure was $26.1 million, up 348.7% from the prior year.
  • Other Non Operating Income for Q2 2026 stood at -$16.0 million, down from $3.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $19.4 million in Q2 2022, with the low at -$19.1 million in Q4 2022.
  • The 5-year median for Other Non Operating Income is $561500.0 (2023), against an average of $1.2 million.
  • Peak annual rise in Other Non Operating Income reached 3966.67% in 2024, while the deepest fall reached 503.98% in 2024.
  • uniQure's Other Non Operating Income stood at -$19.1 million in 2022, then surged by 120.66% to $3.9 million in 2023, then slumped by 503.98% to -$15.9 million in 2024, then soared by 104.7% to $749000.0 in 2025, then tumbled by 2232.18% to -$16.0 million in 2026.
  • Business Quant data shows QURE's Other Non Operating Income at -$16.0 million in Q2 2026, $3.8 million in Q1 2026, and $749000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.97 Mn
Mar 31, 2026 3.77 Mn
Dec 31, 2025 749,000.00
Sep 30, 2025 -7.22 Mn
Jun 30, 2025 18.64 Mn
Mar 31, 2025 7.17 Mn
Dec 31, 2024 -15.94 Mn
Sep 30, 2024 7.56 Mn
Jun 30, 2024 -989,000.00
Mar 31, 2024 -1.15 Mn
Dec 31, 2023 3.95 Mn
Sep 30, 2023 186,000.00
Jun 30, 2023 374,000.00
Mar 31, 2023 -2.37 Mn
Dec 31, 2022 -19.09 Mn
Sep 30, 2022 14.36 Mn
Jun 30, 2022 19.40 Mn
Mar 31, 2022 8.57 Mn
Dec 31, 2021 8.02 Mn
Sep 30, 2021 10.44 Mn